HBM HOLDINGS-B 02142Hong Kong Stock Exchange

11.1405.51%( -0.650 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
HBM HOLDINGS-B (02142) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2020-12-10
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
KYG4403H1002

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)8.71B21/112
Net Profit (Last FY)5.04B7/125
ROE (Last FY)24.88%6/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
王劲松 Executive Director
陈侑晨 Executive Director
刘毅 Executive Director
Robert Irwin Kamen Independent Non-Executive Director
叶小平 Independent Non-Executive Director
Albert R. Collinson Independent Non-Executive Director
陈维维 Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-08-27.

About this page

This page shows HBM HOLDINGS-B (02142) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.